You are here: Industry Insights > Johnson & Johnson

News List

J&J’s Covid-19 vaccine prevents severe disease in preclinical tests pharmaceutical-technology
September 04, 2020
Johnson & Johnson (J&J) has reported that a Covid-19 vaccine candidate, developed by the company’s subsidiary Janssen, prevented severe disease in preclinical studies.
Johnson & Johnson to Acquire Momenta americanpharmaceuticalreview
August 20, 2020
Johnson & Johnson has entered into a definitive agreement to acquire Momenta Pharmaceuticals, a company that discovers and develops novel therapies for immune-mediated diseases, in an all cash transaction for approximately $6.5 billion.
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate expresspharma
August 19, 2020
Brazil’s health regulator Anvisa has approved human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson’s pharma subsidiary Janssen.
UK signs deals with J&J, Novavax for COVID-19 vaccine supplies expresspharma
August 17, 2020
The latest agreements bring Britain’s total number of doses secured to 362 million for a population of 66 million.
Biological E signs tech transfer pacts with Baylor College of Medicine and J&J for COVID-19 vaccine expresspharma
August 14, 2020
The agreements are for Baylor's recombinant protein vaccine candidate and J&J's Ad26.COV2.S vaccine, currently in Phase 1/2 clinical trials.
J&J Announces Agreement with U.S. Government for 100 Million Doses of Investigational COVID-19 Vaccine americanpharmaceuticalreview
August 07, 2020
Johnson & Johnson announced its Janssen Pharmaceutical Companies have entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen’s SARS-CoV-2 investigational ...
J&J signs pact with US for 100 million doses of COVID-19 vaccine expresspharma
August 07, 2020
The US government is committing over $1 billion for this agreement.
J&J Wins $1B U.S. Contract for SARS-CoV-2 Vax contractpharma
August 06, 2020
To provide large scale domestic manufacturing and delivery in the U.S. of 100 million doses of Janssen's SARS-CoV-2 investigational vaccine.
Zhongchao Inc. Renews Contract with Johnson & Johnson (China) Limited, Extending the Cooperation since 2017 prnasia
August 04, 2020
Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a healthcare services company offering patient management, online healthcare information, professional training and educational services, today announced the renewal of contract with Johnson &
J&J begins first trial of Covid-19 vaccine after positive preclinical data pharmaceutical-technology
August 03, 2020
Johnson & Johnson (J&J) has started a Phase I/IIa clinical trial of its Covid-19 vaccine candidate, Ad26.COV2.S, in healthy volunteers across the US and Belgium.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 15 16 Next page